secwatch.observer — SEC 8-K summary
======================================

Issuer:     ZEVRA THERAPEUTICS, INC. (ZVRA)
CIK:        0001434647
Form:       8-K
Filed at:   2025-05-29T23:59:59+00:00
Accession:  0001193125-25-130714
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Zevra Therapeutics stockholders elect Dixon and Favorito as Class I directors
-----------------------------------------------------------------------------

- Wendy Dixon elected with 25.8M for (9.1M withheld); Tamara Favorito with 25.6M for (9.3M withheld). Broker non-votes ~9.65M.
- Dissident Mangless failed to comply with Rule 14a-19 and bylaws; his nominees Mickle and Regan disregarded despite 9.2M and 8.4M votes.
- Ratification of Ernst & Young as auditor passed: 43.8M for, 360k against, 382k abstain; no broker non-votes.
- 81.4% of outstanding shares (44.5M of 54.7M) were present or represented at the May 29, 2025 meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1434647/000119312525130714/0001193125-25-130714-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1434647/000119312525130714/d54488d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-130714

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer